Ocular Therapeutix Inc. (OCUL)
5.89
-1.25 (-17.51%)
At close: Mar 03, 2025, 3:59 PM
5.93
0.59%
After-hours: Mar 03, 2025, 04:16 PM EST
Ocular Therapeutix Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 195.81M | 102.3M | 164.16M | 228.06M | 54.44M | 54.06M | 41.54M | 32.94M | 30.78M | 37.39M | 17.5M | 23.85M |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 35.21M | 74.28M | 37.44M | n/a | n/a |
| Long-Term Investments | n/a | 1.76M | 1.76M | 1.76M | 1.76M | 6.61M | 1.61M | 1.73M | 228K | n/a | n/a | n/a |
| Other Long-Term Assets | 1.61M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 228K | 228K | 238K |
| Receivables | 26.18M | 21.32M | 21.14M | 12.25M | 2.55M | 201K | 226K | 250K | 193K | 329K | 269K | 45K |
| Inventory | 2.31M | 1.97M | 1.25M | 1.2M | 954K | 217K | 122K | 113K | 134K | 133K | n/a | n/a |
| Other Current Assets | 7.94M | 4.03M | 9.5M | 8.04M | 4.46M | 3.43M | 1.45M | 2.78M | 3.18M | 893K | 240K | 726K |
| Total Current Assets | 232.24M | 129.63M | 191.3M | 246.16M | 60.17M | 56.19M | 43.34M | 69.9M | 106.98M | 76.18M | 18.01M | 24.26M |
| Property-Plant & Equipment | 18.21M | 17.9M | 11.82M | 13.94M | 16.81M | 10.24M | 10.48M | 3.31M | 3.1M | 1.78M | 904K | 785K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 19.82M | 19.66M | 13.59M | 15.7M | 18.57M | 16.85M | 12.09M | 5.04M | 3.32M | 2.01M | 1.13M | 1.02M |
| Total Assets | 252.06M | 149.29M | 204.89M | 261.86M | 78.74M | 73.04M | 55.43M | 74.94M | 110.31M | 78.19M | 19.15M | 25.29M |
| Account Payables | 4.39M | 5.12M | 4.59M | 2.71M | 3.27M | 2.96M | 3.57M | 2.12M | 1.96M | 1.32M | 545K | 583K |
| Deferred Revenue | 255K | 576K | 13M | 12M | n/a | n/a | n/a | n/a | 42K | 188K | 250K | n/a |
| Short-Term Debt | 1.59M | 3.2M | 3.25M | 11.01M | 2.25M | n/a | 5.54M | 1.55M | n/a | 1.35M | 1.81M | 1.81M |
| Other Current Liabilities | 28.67M | 22.5M | 18.5M | 12.95M | 6.51M | 6.19M | 4.31M | 4.63M | 3.38M | 3.02M | 741K | 1.09M |
| Total Current Liabilities | 34.9M | 31.39M | 26.34M | 26.66M | 12.03M | 9.16M | 13.43M | 8.3M | 5.38M | 5.87M | 3.34M | 3.48M |
| Long-Term Debt | 81.8M | 62.68M | 57.36M | 48.79M | 58.22M | 24.79M | 12.47M | 14.09M | 15.27M | 13.51M | 651K | 2.26M |
| Other Long-Term Liabilities | 30.09M | 6.44M | 20.19M | 98.31M | 12.12M | 3.22M | 3.39M | 537K | 68K | 112K | 74.63M | 66.16M |
| Total Long-Term Liabilities | 126.03M | 82.52M | 90.55M | 159.1M | 70.34M | 28.01M | 15.86M | 14.63M | 15.34M | 13.62M | 75.28M | 68.42M |
| Total Liabilities | 160.93M | 113.91M | 116.89M | 185.77M | 82.37M | 37.17M | 29.28M | 22.93M | 20.72M | 19.5M | 78.62M | 71.9M |
| Total Debt | 83.39M | 64.28M | 58.98M | 58.44M | 59.34M | 24.79M | 18.02M | 15.64M | 15.27M | 14.87M | 2.46M | 4.07M |
| Common Stock | 12K | 8K | 8K | 8K | 5K | 4K | 3K | 3K | 2K | 2K | n/a | n/a |
| Retained Earnings | -697.58M | -616.84M | -545.8M | -539.25M | -383.62M | -297.24M | -237.26M | -173.88M | -129.18M | -89.43M | -60.78M | -47.46M |
| Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5K | -68K | -2.22M | -1.68M | -1.27M |
| Shareholders Equity | 91.13M | 35.38M | 88M | 76.09M | -3.63M | 35.88M | 26.15M | 52.01M | 89.59M | 58.7M | -59.47M | -46.61M |
| Total Investments | 1.61M | 1.76M | 1.76M | 1.76M | 1.76M | 6.61M | 1.61M | 35.21M | 74.28M | 37.44M | n/a | n/a |